Table: RaQualia Pharma - 6-MTH group results

RaQualia Pharma

10/08/2018 07:30

Aug 10 (Reuters)- 
             RaQualia Pharma Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Jun 30, 2018        Jun 30, 2017      Dec 31, 2018  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            445 mln             463 mln            1.39      
                 (-3.8 pct)                            (-2.2 pct)   
  Operating     loss 558 mln        loss 352 mln      loss 698 mln  
  Recurring     loss 569 mln        loss 300 mln      loss 680 mln  
  Net           loss 596 mln        loss 287 mln      loss 686 mln  
  EPS          loss 29.32 yen      loss 14.99 yen    loss 33.84 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - RaQualia Pharma Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4579.T